182 related articles for article (PubMed ID: 35182547)
21. Structural basis of STAT2 recognition by IRF9 reveals molecular insights into ISGF3 function.
Rengachari S; Groiss S; Devos JM; Caron E; Grandvaux N; Panne D
Proc Natl Acad Sci U S A; 2018 Jan; 115(4):E601-E609. PubMed ID: 29317535
[TBL] [Abstract][Full Text] [Related]
22. Structural and functional characterization of salmon STAT1, STAT2 and IRF9 homologs sheds light on interferon signaling in teleosts.
Sobhkhez M; Skjesol A; Thomassen E; Tollersrud LG; Iliev DB; Sun B; Robertsen B; Jørgensen JB
FEBS Open Bio; 2014; 4():858-71. PubMed ID: 25379383
[TBL] [Abstract][Full Text] [Related]
23. Interaction of IRF9 and STAT2 synergistically up-regulates IFN and PKR transcription in Ctenopharyngodon idella.
Wu Z; Wang L; Xu X; Lin G; Mao H; Ran X; Zhang T; Huang K; Wang H; Huang Q; Xu Q; Hu C
Mol Immunol; 2017 May; 85():273-282. PubMed ID: 28347954
[TBL] [Abstract][Full Text] [Related]
24. Formation of STAT1-STAT2 heterodimers and their role in the activation of IRF-1 gene transcription by interferon-alpha.
Li X; Leung S; Qureshi S; Darnell JE; Stark GR
J Biol Chem; 1996 Mar; 271(10):5790-4. PubMed ID: 8621447
[TBL] [Abstract][Full Text] [Related]
25. Reovirus mu2 protein inhibits interferon signaling through a novel mechanism involving nuclear accumulation of interferon regulatory factor 9.
Zurney J; Kobayashi T; Holm GH; Dermody TS; Sherry B
J Virol; 2009 Mar; 83(5):2178-87. PubMed ID: 19109390
[TBL] [Abstract][Full Text] [Related]
26. Selective STAT protein degradation induced by paramyxoviruses requires both STAT1 and STAT2 but is independent of alpha/beta interferon signal transduction.
Parisien JP; Lau JF; Rodriguez JJ; Ulane CM; Horvath CM
J Virol; 2002 May; 76(9):4190-8. PubMed ID: 11932384
[TBL] [Abstract][Full Text] [Related]
27. Expression regulation of zebrafish interferon regulatory factor 9 by promoter analysis.
Shi J; Zhang YB; Zhang JS; Gui JF
Dev Comp Immunol; 2013 Dec; 41(4):534-43. PubMed ID: 23916490
[TBL] [Abstract][Full Text] [Related]
28. The Measles Virus V Protein Binding Site to STAT2 Overlaps That of IRF9.
Nagano Y; Sugiyama A; Kimoto M; Wakahara T; Noguchi Y; Jiang X; Saijo S; Shimizu N; Yabuno N; Yao M; Gooley PR; Moseley GW; Tadokoro T; Maenaka K; Ose T
J Virol; 2020 Aug; 94(17):. PubMed ID: 32581091
[TBL] [Abstract][Full Text] [Related]
29. IRF7-dependent type I interferon production induces lethal immune-mediated disease in STAT1 knockout mice infected with lymphocytic choriomeningitis virus.
Li W; Hofer MJ; Jung SR; Lim SL; Campbell IL
J Virol; 2014 Jul; 88(13):7578-88. PubMed ID: 24760883
[TBL] [Abstract][Full Text] [Related]
30. IFN-type-I-mediated signaling is regulated by modulation of STAT2 nuclear export.
Frahm T; Hauser H; Köster M
J Cell Sci; 2006 Mar; 119(Pt 6):1092-104. PubMed ID: 16507591
[TBL] [Abstract][Full Text] [Related]
31. STAT2-dependent induction of RNA adenosine deaminase ADAR1 by type I interferon differs between mouse and human cells in the requirement for STAT1.
George CX; Samuel CE
Virology; 2015 Nov; 485():363-70. PubMed ID: 26335850
[TBL] [Abstract][Full Text] [Related]
32. ADAR1 Suppresses Interferon Signaling in Gastric Cancer Cells by MicroRNA-302a-Mediated IRF9/STAT1 Regulation.
Jiang L; Park MJ; Cho CJ; Lee K; Jung MK; Pack CG; Myung SJ; Chang S
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867271
[TBL] [Abstract][Full Text] [Related]
33. The emerging role of interferon regulatory factor 9 in the antiviral host response and beyond.
Suprunenko T; Hofer MJ
Cytokine Growth Factor Rev; 2016 Jun; 29():35-43. PubMed ID: 26987614
[TBL] [Abstract][Full Text] [Related]
34. STAT and Janus kinase targeting by human herpesvirus 8 interferon regulatory factor in the suppression of type-I interferon signaling.
Xiang Q; Yang Z; Nicholas J
PLoS Pathog; 2022 Jul; 18(7):e1010676. PubMed ID: 35776779
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-17A pretreatment attenuates the anti-hepatitis B virus efficacy of interferon-alpha by reducing activation of the interferon-stimulated gene factor 3 transcriptional complex in hepatitis B virus-expressing HepG2 cells.
Zhang J; Liu K; Zhang G; Ling N; Chen M
Virol J; 2022 Feb; 19(1):28. PubMed ID: 35144643
[TBL] [Abstract][Full Text] [Related]
36. HCV NS5A and IRF9 compete for CypA binding.
Bobardt M; Hopkins S; Baugh J; Chatterji U; Hernandez F; Hiscott J; Sluder A; Lin K; Gallay PA
J Hepatol; 2013 Jan; 58(1):16-23. PubMed ID: 22902549
[TBL] [Abstract][Full Text] [Related]
37. Phosphorylation of interferon regulatory factor 9 (IRF9).
Paul A; Ismail MN; Tang TH; Ng SK
Mol Biol Rep; 2023 Apr; 50(4):3909-3917. PubMed ID: 36662450
[TBL] [Abstract][Full Text] [Related]
38. Noncanonical Effects of IRF9 in Intestinal Inflammation: More than Type I and Type III Interferons.
Rauch I; Rosebrock F; Hainzl E; Heider S; Majoros A; Wienerroither S; Strobl B; Stockinger S; Kenner L; Müller M; Decker T
Mol Cell Biol; 2015 Jul; 35(13):2332-43. PubMed ID: 25918247
[TBL] [Abstract][Full Text] [Related]
39. Kobuvirus VP3 protein restricts the IFN-β-triggered signaling pathway by inhibiting STAT2-IRF9 and STAT2-STAT2 complex formation.
Peng Q; Lan X; Wang C; Ren Y; Yue N; Wang J; Zhong B; Zhu Q
Virology; 2017 Jul; 507():161-169. PubMed ID: 28441586
[TBL] [Abstract][Full Text] [Related]
40. The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2.
Parisien JP; Lau JF; Rodriguez JJ; Sullivan BM; Moscona A; Parks GD; Lamb RA; Horvath CM
Virology; 2001 May; 283(2):230-9. PubMed ID: 11336548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
